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The synthetic food dyes studied were rose bengal (RB), phroxine (PL), amaranth, erythrosine B (ET), allura red, new coccine,
acid red (AR), tartrazine, sunset yellow FCF, brilliant blue FCF, and indigo carmine. First, data conﬁrmed that these dyes were
not substrates for CYP2A6, UGT1A6, and UGT2B7. ET inhibited UGT1A6 (glucuronidation of p-nitrophenol) and UGT2B7
(glucuronidationofandrosterone).WeshowedtheinhibitoryeﬀectofxanthenedyeonhumanUGT1A6activity.BasicET,PL,and
RB in those food dyes strongly inhibited UGT1A6 activity, with IC50 values = 0.05, 0.04, and 0.015mM, respectively. Meanwhile,
AR of an acidic xanthene food dye showed no inhibition. Next, we studied the inhibition of CYP3A4 of a major phase I drug-
metabolizing enzyme and P-glycoprotein of a major transporter by synthetic food dyes. Human CYP3A4 and P-glycoprotein were
also inhibited by basic xanthene food dyes. The IC50 values of these dyes to inhibit CYP3A4 and P-glycoprotein were the same as
the inhibition level of UGT1A6 by three halogenated xanthene food dyes (ET, PL, and RB) described above, except AR, like the
results with UGT1A6 and UGT2B7. We also conﬁrmed the noninhibition of CYP3A4 and P-gp by other synthetic food dyes. Part
of this inhibition depended upon the reaction of
1O2 originating on xanthene dyes by light irradiation, because inhibition was
preventedby 1O 2 quenchers.Westudiedtheinﬂuenceofsuperoxidedismutaseandcatalaseonthisinhibitionbydyesandwefound
prevention of inhibition by superoxide dismutase but not catalase. This result suggests that superoxide anions, originating on dyes
by light irradiation, must attack drug-metabolizing enzymes. It is possible that red cosmetics containing phloxine, erythrosine, or
rose bengal react with proteins on skin under lighting and may lead to rough skin.
Copyright © 2009 Takaharu Mizutani. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
The study of drug metabolism started from the conjugation
between glycine and benzoic acid to hippuric acid in horse
urine by Wohler in 1824. He synthesized an organic com-
pound, urea, in the ﬁrst instance and also found aluminum.
The study of drug metabolism has advanced according
to developments in chemistry and the chemical industry
since the nineteenth century; however, drug-metabolizing
enzymes did not originate from chemistry development
but rather were developed to excrete natural substances
of low molecular weight, mainly plant materials such as
catechols, terpenoids, alkaloids, ﬂavonoids, lignins, and
amines, ingested by the body with ﬁve major nutrients
(carbohydrates, proteins, lipids, vitamins, and minerals) in
foods from when living things were created, 3.5billion years
ago or earlier [1]. We drink coﬀee and juice, which contain
nonnutrient materials and ﬁbers that pass through the body
asfeces.Caﬀeineandchlorogenicacidaremajorconstituents
in coﬀee and are also ingested and metabolized by so-called
drug-metabolizing enzymes. Many of these small materials
should be excreted in urine from the kidneys and in bile
fromtheliverafterphaseIandIIdrug-metabolizingenzymes
and transporters react with them. Phase I drug-metabolizing
enzyme is mainly composed of cytochrome P450 (CYP),
which was identiﬁed by Omura and Sato [2]. In grapefruit
juice, some unknown constituents inhibit drug metabolism
by CYP3A4 of a major phase I drug-metabolizing enzyme.
Of course, some drug-metabolizing enzymes play a key
role in reacting with endogenous substances to be excreted,
such as bilirubin and steroid hormones. Other phase I
metabolizing enzymes, such as CYP11, CYP17, and CYP19,
play an essential role in producing steroid hormones, such
as testosterone, estradiol, aldosterone, progesterone, and2 Journal of Environmental and Public Health
corticosterones,fromcholesterolthroughpregnenolone.The
substrate speciﬁcity of these steroid synthesizing enzymes is
narrow compared with that of CYPs for drug metabolism;
which also produce vitamin D and retinoids. The CYP levels
inhumanliver(about1kg)are2%to4%ofthetotalprotein;
this means that the amount of CYP is approximately 5–
10g in the liver (the high level is in the case of induction
by phenobarbital). Poor metabolizer frequencies of major
CYPsinAsiansandCaucasianshavebeensummarized[3].In
poor metabolizers, drugs are not metabolized and high drug
levelsinbloodaremaintained,withtoxiceﬀectsappearingin
patients. These CYPs are present in the smooth endoplasmic
reticulum and are recovered in microsomal fractions in
experiments. A major phase II drug-metabolizing enzyme,
UDP-glucuronosyltransferase (UGT), is also contained in
microsomal fractions in the liver to the same level of CYPs.
Thus, these CYPs and UGTs are major protein constituents
in microsomes and a few CYPs and UGTs might be coupled
and co-operate with each other in membranes.
Most xenobiotics, such as drugs, nonnutrient substances
of low molecular mass in foods, and pollutants, are absorbed
and then metabolized by phase I drug-metabolizing
enzymes, followed by phase II enzymes, and ﬁnally excreted
through transporters (phase III enzymes). Many drugs are
lipophilic and persist in lipophilic membranes composed
of lipid matrix. Phase I enzymes convert lipophilic drugs
to potentially reactive products and make compounds less
toxic [4], and then phase II drug-metabolizing enzymes
conjugate with water-soluble substances, such as UDPGA
forUDP-glucuronosyltransferase(UGT)[5],PAPSforsulfo-
transferase [6], and GSH for glutathione S-transferase. UGT
is the most functional enzyme among phase II enzymes.
Drugs, their metabolites and conjugates with glucuronic
acid, sulfate, and glutathione, are excreted by transporters
from the liver in bile, from the kidneys in urine and from
skin in sweat. The major transporters in the liver include
P-glycoprotein (P-gp), MDR-relating protein 2 (MRP2,
ABCC2), Organic-anion transporting peptide 2 (OATP2),
and bile salt exporting protein (BSEP). P-gp functions as
a key protein of the blood-brain barrier and a major drug
transporter and prevents anticancer drugs from entering
in cancer cells during chemotherapy [7]. Dubin-Johnson
syndrome, human jaundice, is induced by a deﬁciency
of MRP2 [8]. These transporters operate in the plasma
membrane.
With the development of storage and manufacturing
methods, processed foods constitute 60% of total foods and
are increasing annually. The need for food additives is also
increasing [9, 10] .T h e s ec h e m i c a lf o o dd y e sa r ea l s ou s e d
for coloring cosmetics and pills as well as foods. Erythrosine
(ET) is used as a staining dye for dead Schizosaccharomyces
pombe [11] and to investigate dead bacteria in human
dental caries. During re-evaluation of the safety of these
additives, some materials have disappeared. For example,
permission to use butter yellow, an azo-dye, was withdrawn
due to carcinogenicity within a year after it was granted.
Twelve chemical food dyes are permitted by the Japanese
Government [12]. There have been some reports showing
the inhibition of enzyme activity, such as choline esterase
inhibition by ET and sunset yellow, inhibition of sulfation
of 17 β-ethinylestradiol by ET [13, 14], and inhibition of
dopamine sulfation by tartrazine [15]. The inhibition of
some CYPs by purpurin and alizarin has also been reported
[16]. Meanwhile, amaranth has not been permitted in the
USA since 1976 but is permitted in Japan. Most chemical
pigments possess anionic sulfate residues that prevent the
absorption of pigments in the gastrointestinal tract [10].
Some azo-dyes are reduced by enterobacteria in the intestine
and are absorbed in the body [12]. Toxicity studies of these
pigments in humans are diﬃcult for many reasons, thus,
toxicity studies depend on experimental results in animals
[17].
Phenyl-xanthene dyes, such as rose bengal (RB), ET,
phloxine (PL), eosin (ES), uranine (UR), rhodamine (RM),
and ﬂuorescein, are known as light-enhancing reagents
(catalytic light reaction) by the generation of 1O2 on the
dyes [18–24]. There are two types of reaction: the ﬁrst is that
drug energy enhanced by light is transferred to biomolecules
and free radicals originate on the molecules. The second
is that energy is transferred to oxygen, which changes to
1O2. This reaction depends upon the number of halogens
on xanthene dyes and the light strength. There are some
papers on the inactivation of enzymes by xanthene dyes.
Na,K-ATPase was inactivated by light in the presence of
RB [24, 25]. Acetylcholineesterase and some microorganims,
such as Escherichia coli, Staphylococcus aureus, and inﬂuenza
virus, are inactivated [18, 19, 23, 26].
Inthisreviewaboutsafetytestingofhuman-speciﬁcdrug
metabolites, we showed inhibition of xanthene food dyes for
drug-metabolizing enzymes, summarized from our reports
[27–29]. Meanwhile, we have also investigated the induction
of human UGT1A1 by bilirubin [5, 30–34], autoantibodies
in autoimmune hepatitis patients [35–38], participation
o fh u m a nU G T 1 A 6i nd r u gi n t e r a c t i o nb e t w e e nv a l p r o a t e
and capbapenem antibiotics [39–41], structure-function
relationships of some opioid derivatives for human UGT2B7
[42], and recent progress of the endogenous function of P-gp
[43–46].
2. Experimental
2.1. Dyes. The chemical food dyes used were phloxine (PL,
Food Red no. 104), rose bengal (RB, Food Red no. 105),
erythrosine (ET, Food Red no. 3), amaranth (AM, Food
Red no. 2), allura red (AL, Food Red no. 40), new coccine
(NC, Food Red no. 102), acid red (AR, Food Red no. 106),
tartrazine (TT, Food Yellow no. 4), sunset yellow FCF (SY,
Food Yellow no. 5), brilliant blue FCF (BB, Food Blue no. 1),
and indigo carmine (ID, Food Blue no. 2), and parts of their
structures are shown in Figure 1. These are products of San-
Eigen Co. Ltd (Osaka, Japan) and have oﬃcial approval for
purity and safety from the Japanese Government. These dyes
are well soluble in water and the solutions are used at various
appropriate concentrations.
2.2. Drug-Metabolizing Enzymes. The enzyme source to
measure CYP2A6, CYP3A4, and UGT1A6 activities wasJournal of Environmental and Public Health 3
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Figure 1: Chemical structure of xanthene food dyes.
pooled human liver microsomes (HLMs), purchased
from Gentest (Woburn, MA, USA). UGT2B7 and
P-gp membrane are products prepared in an Sf9 cell
membrane using a baculovirus expression system supplied
by Gentest. These enzymes were stored at −80
◦C.
Superoxide dismutase (SOD) and catalase are products
of Sigma.
2.3. Assay of Drug-Metabolizing Enzymes. Coumarin 7-
hydroxylationactivity(CYP2A6)wasmeasuredaspreviously
reported [47, 48] and originally [49]. The assay of CYP3A4
activity was carried out according to the method [50].
The substrate used was 7-benzoyloxy-4-(triﬂuoromethyl)-
coumarin and the standard chemical of the product was
7-hydroxy-triﬂuoromethyl-coumarin, supplied by Gentest.4 Journal of Environmental and Public Health
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Figure 2: Inhibition of CYP3A4 activity by erythrosine (ET) and
amaranth (AM).
The microassay method of UGT activity in this study was
carried out according to previous reports [5, 51]. ATPase
activity of P-gp is generally measured according to the
protocol [52] described on the data sheet from Gentest. In
order to investigate the role of reactive oxygen species on the
inhibition of UGT1A6 by dyes, we studied the eﬀect of SOD
and catalase.
2.4. Statistical Analyses. The mean ± S.D value of each
point was calculated from 3 determinations. Validity of the
inhibition was examined by Student’s t-test for diﬀerences in
the presence (control) and absence of inhibitors. Signiﬁcant
values at the 5% level of signiﬁcance were taken as eﬀective.
∗Signiﬁcant from the control (P<. 05); ∗∗,( P<. 01).
3. Inhibition of CYP Activity by
ChemicalFoodDyes
CYP3A4 is a major enzyme among phase I drug-
metabolizing enzymes and reacts with half of all drugs. To
determine the inﬂuence of CYP3A4 activity by food dyes, the
color of dyes inﬂuencing the ﬂuorometric measurement over
30μM dye concentration was measured. This background
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Figure 3: Inhibition of glucuronidation of UGT1A6 by chemical
food dyes.
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Figure 4: Lineweaver-Burk plots of UGT1A6 by erythrosine (ET).
Closed squares and shaded squares are 0.05mM ET and absence of
ET, respectively.
was subtracted from the measurement of color pigments.
Figure 2 shows the inhibition of CYP3A4 by ET, which was
completely inhibited at 30μM, and shows noninhibition by
AM.TheseIC50 valuesareshowninTable1.Otherxanthenes
food dyes (PL, RB and AR) also showed inhibition but
other food dyes did not inhibit the reaction of CYP3A4. We
omitted the non-inhibition patterns of many other dyes in
Table 1.AsshowninTable1,IC 50 valuesforCYP3A4reaction
were similar to the values obtained by UGT1A6 reaction
described later [28], except for AR, which did not inhibit the
UGT1A6 reaction, but the CYP3A4. We could not explain
this discrepancy.
4. Inhibition of UGT1A6 andUGT2B7 by
FoodDyes
The inhibition of UGT1A6 activity with p-nitrophenol [5]
and of UGT2B7 with androsterone by dyes was studied.
Figure 3 shows the concentration-dependent inhibitionJournal of Environmental and Public Health 5
Table 1: Summary of IC50 values of CYP3A4, UGT1A6, and P-glycoprotein inhibition by chemical food dyes.
Dye IC50 value (μM)
CYP3A4 UGT1A6 P-glycoprotein
Phloxine (PL) 5.6 40 24.5
Rose Bengal (RB) 21.2 15 11.7
Erythrosine B (ET) 7.9 50 15.6
Acid red (AR) 10.3 >1000 >1000
Amaranth (AM) >1000 >1000 >1000
Allura red (AL) >1000 >1000 >1000
New coccine (NC) >1000 >1000 >1000
Tartrazine (TT) >1000 >1000 >1000
Sunset yellow FCF (SY) >1000 >1000 >1000
Brilliant blue FCF (BB) >1000 >1000 >1000
Indigo carmine (ID) >1000 >1000 >1000
patterns of UGT1A6 by chemical food dyes. The greatest
inhibition was found with ET. Dyes showing insigniﬁcant
inhibition were AM, AL, NC, and BB. Pigments, such as
AR, TT, SY, and IC, showed no inhibition. The results of
the autoradiogram showed inhibition of UGT1A6 activity
by ET in a concentration-dependent manner. The density
(radioactivity) of the products became weaker relative to the
ET concentration (data not shown). The result also shows
that ET had no substrate activity, as did the Lineweaver-
Burk plots of UGT1A6 in the presence of ET, indicating a
noncompetitive manner, as shown in Figure 4. The same
inhibition pattern was found in UGT2B7 with androsterone.
ThisinhibitionpatternofUGT2B7bydyeswasparalleltothe
patternobtainedwithUGT1A6inFigure3.TheseIC50 values
are summarized in Table 1.T h eI C 50 value of inhibition
by ET for UGT2B7 was similar to the value for UGT1A6.
The IC50 values of inhibition by AM, AL, NC, BB, AR, TT,
SY and ID were higher than 2mM and showed almost no
inhibition. Thus, ET, RB, PL of basic xanthenes dyes showed
speciﬁc inhibition of UGT1A6 and 2B7 in a non-competitive
manner.
From the structure-function relationships in glu-
curonidation inhibition, it is very interesting that halo-
genated xanthene dyes, such as ET, RB, and PL, have
inhibitory activity against UGT. Thus, we studied the
inhibition of UGT1A6 by other xanthene dyes, Eosin Y (ES)
and Eosin-5-isothiocyanate (E5ic), of nonpermitted dyes.
These dyes inhibited UGT activity and those IC50 values of
ET, RB, PL, ES, E5ic were 0.07, 0.015, 0.04, 0.12, 0.07mM,
respectively (data not shown). At a concentration of 0.5mM,
the dyes almostly totally inhibited glucuronidation activity.
Meanwhile, nonhalogenated xanthene dyes, such as AR,
rhodamine, Uranine, and Xanthene, did not inhibit the
activity of UGT1A6. These IC50 values were higher than
1mM. From these results, we considered that halogenated-
aromatic compounds should inhibit UGT1A6 activity. Next
we studied inhibition by high-halogenated compounds,
such as ioxaglic acid, iodixanol, meglumine iotalamate
for contrast media, and sodium diatrizoate for leucocyte
preparation; however, we found no inhibition using these
high-halogenated compounds.
From these results, we considered that the halogenated
xanthene backbone is a key structure and iodine is the most
potent element among halogens, because RB containing
iodine is more potent than PL containing bromine. It is
possible that the resonating double bond continuing from
a carbonyl bond on the xanthene backbone is essential, as
well as halogens on the xanthene backbone itself, in Figure 1.
Phenyl residues on xanthene dyes may be another important
r e s i d u ea sw e l la sh a l o g e n so np h e n y lr e s i d u e s .
5. Inhibition of P-Glycoprotein Activity by
Chemical Dyes
The inhibition of P-gp by three halogenated xanthene dyes,
PL, ET, and RB was conﬁrmed. In the reaction of P-gp,
inhibition by dye at 30μM was not complete and these IC50
values are shown in Table 1, which also shows the results
of inhibition of UGT1A6 and P-gp activities. The strongest
inhibitor of CYP3A4 and P-gp activities is RB as in the
inhibitionofUGT1A6activity.Otherdyesdidnotinhibitthe
P-gp reaction. Thus, three halogenated xanthene food dyes
(ET, RB, and PL) well inhibited CYP3A4, UGT1A6, and P-
gp.
CYP3A4 is the most active enzyme among phase I drug-
metabolizing enzymes, and UGT1A6 is the major enzyme
among phase II drug-metabolizing enzymes. P-gp is the
most active enzyme among ABC transporters. Thus, three
halogenated xanthene food dyes inhibited these major drug-
metabolizing enzymes.
6. Inﬂuence of
1O2 Quenchers
The inhibition of UGT by xanthene dyes was conﬁrmed
as a non-competitive type mechanism from the pattern by
Lineweaver-Burk plots, as shown in Figure 4 [27]. This
indicates that inhibition relates to the velocity of the enzyme
reaction and involves enzyme inactivation. In order to clarify
the mechanisms, we studied the inﬂuence of 1O2 quenchers,
such as NaN3, histidine, and β-carotene on glucuronidation6 Journal of Environmental and Public Health
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Figure 5: Eﬀect of D2O (closed circles) and H2O (closed squares)
on glucuronidation inhibition of p-Nitrophenol by RB.
inhibition by RB. We also investigated the inﬂuence of D2O
on the glucuronidation reaction.
NaN3 and hisitidine signiﬁcantly prevented the inhi-
bition by RB, but β-carotene did not [28]. NaN3 and
hisitidine are soluble in the reaction mixture but β-carotene
is insoluble, so we could not obtain clear results with β-
carotene. The prevention of RB inhibition by NaN3 and
histidine suggests that part of the inhibition by RB depended
upon 1O2 originating on RB molecules activated by light
Figure 5 shows inhibition of the increase by RB in D2O
solution and comparison of the activity in water and D2O,
andtheresultshowsthattheactivityinD2Oisapproximately
half of the activity in H2O. This may be because part of this
decrease (increase of inhibition by RB) in activity depends
upon the long presence (slow disappearance) of 1O2 in
D2O solution, as well as the slightly higher viscosity of D2O
solution. These quenchers (NaN3, histidine, and β-carotene)
themselves showed no inhibition of glucuronidation of p-NP
by UGT1A6 in the range of concentration from 1 to 20 mM
of NaN3 and histidine, and 0.2–0.5mM of β-carotene.
The inﬂuence of light on RB inhibition was studied. This
experiment was carried out at 0.3mM p-NP. We found a
signiﬁcant diﬀerence between the values of activity in the
darkandlightatlowconcentrations,0.01,0.02,and0.05mM
of RB. This result suggests that weak inhibition by RB in
the dark may depend on the low generation of 1O2 in the
dark. We could not ﬁnd a signiﬁcant diﬀerence at a high
concentration, 0.1mM, of RB. This inhibition in the dark at
0.1mMRBindicatesthatthisinhibitiondependsonnotonly
1O2 but also unknown factors.
7. Prevention of Inhibition of UGT1A6 with
SOD andCatalase
In order to clarify the mechanism of inhibition by dyes, we
added SOD or catalase to the mixture of UGT1A6 inhibition
by ET. As shown in Figure 6, the product (p-nitrophenol-
glucuronide) was low in the absence of SOD, as shown on
the left. The product increased according to the increase of
the amount of SOD added to the inhibition mixture by ET.
PreventionbySODwassigniﬁcantlyfoundincolumnsinthe
presence of SOD, showing that superoxide anions are related
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Figure 6: Prevention of inhibition of UGT1A6 activity by SOD of
O2- quencher. Signiﬁcance indicated by asterisk, at P<.05.
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Figure 7: Scheme of inhibition by active oxygen species.
to inhibition by dyes. Consumption of superoxide anions
by SOD recovered from the inhibition by dyes. SOD did
not completely restore activity in the presence of inhibitor,
possibly suggesting an alternative mechanism in addition to
the free radical hypothesis. Superoxide anions may come
from oxygen radicals originating on dye molecules by light
irradiation.
We found no prevention of catalase inhibition. With a
high amount of catalase, inhibition of ET was found at an
identical inhibition level to that in the absence of catalase.
These results indicate that hydroxyl peroxide did not relate
withtheinhibitionofUGT1A6activitybyET.Figure7shows
the production pathway of active oxygen by light irradiation
and a possible inhibition mechanism by dyes. Superoxide
anions come from singlet oxygen and attack enzymes, such
as CYP3A4, UGT1A6, and P-gp in membranes. Meanwhile,
superoxide anions were hydrolyzed by SOD and inhibition
by dyes was prevented by the decrease of superoxide anions
by SOD.
8. Discussion
Chemical food additive dyes are large molecular masses
having a strong anionic charge of sulfate or cationic charge
on the molecule to prevent absorption in the gastrointestinal
tract. It has been described that a few parts of those pigments
are absorbed [12]. Approximately 2mg total pigments/day
are ingested and the concentration in the body is estimated
t ob e2n M .T h i sl e v e li sl o w e r( 1 / 1 0 5) than the IC50 value ofJournal of Environmental and Public Health 7
RB (0.015mM), PL (0.04mM) and, ET (0.05mM) for UGT.
Thus, these dyes should not inﬂuence drug metabolism and
inhibition under normal conditions in the body; however,
it is necessary for some patients with ulcers in the gut
to avoid the ingestion of chemical food dyes. It is also
possible that some cosmetics contain red xanthene dyes,
activated by light irradiation, which may injure and lead
to rough skin. Thus, it is recommended for a person with
facial inﬂammation to avoid cosmetics. In the previous
report [29], we showed that halogenated xanthene dyes
inhibited CYP3A4, UGT1A6, and P-gp activities of major
drug-metabolizing enzymes.
It has been reported that xanthene dyes generate 1O2
in light [18–23]. The inactivation of enzymes by xanthene
dyes may well proceed in aerobic conditions through type
II mechanisms of 1O2 generation. It was reported that
1O2 generation on xanthene dyes is RB>ET>PL>ES UR
[19]. By this experiment, the strength of inhibition is
RB>PL>ET>E5ic>ES AR, RM, and UR. This order of
inhibition by our study is similar to 1O2 generation.
We showed that inhibition by RB was prevented by 1O2
quenchers,suchasNaN3 andhistidine[28].Theinﬂuenceby
β-carotene of another quencher was not clear and may come
from the insolubility of β-carotene. With D2O, inhibition by
RB was promoted, suggesting, the 1O2 played a role in the
inhibition function, because of the 16-time long reservation
of 1O2 in 1O2 solution [25]; however, the quencher results
were not complete but partial eﬀects in our study. The
reason is that UGT1A6 is not a soluble but a membrane-
bound enzyme and is buried in lipid bilayers which protect
UGT1A6 from 1O2 attack. In this review, we showed
that SOD prevented the inhibition of UGT1A6 activity by
ET. Superoxide anions partially come from singlet oxygen,
which originates on dyes by light irradiation. This result
suggests that superoxide anions play a role in inhibition by
dyes.
There are few studies available for human CYP3A4 as
a major phase 1 drug-metabolizing enzyme and human P-
gp as a major transporter involving chemical food dyes.
Many studies have been carried out on the toxicity and
carcinogenicity of chemical food dyes [9, 15]. Our pre-
vious results showed that the activity levels of CYP2A6
and UGT in bovine liver microsomes were similar to
human liver microsomes [5, 46, 47], but diﬀered from rat
microsomes, as rat microsomes did not involve CYP2A6
activity. Thus, it was considered that bovine microsome
data were very similar to human microsome data. From the
structure-function relationships in glucuronidation inhibi-
tion, it was suggested that halogenated, resonating, aromatic
xanthene compounds might provide a condition for 1O2
generation to inhibit enzymes. This result suggests that
superoxide anions, originating on dyes by light irradia-
tion, must attack drug-metabolizing enzymes. It is also
possible that metabolites of chemical food dyes play a
role in denaturing drug-metabolizing enzymes in human
microsomes, and also, red cosmetics containing phloxine,
erythrosine or rose bengal react with proteins on skin
under lighting by generating radicals and may lead to rough
skin.
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